Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

U.S. FDA Grants Fast Track designation To Ofra-Vec (VB-111) For Platinum-Resistant Ovarian Cancer

VBL Therapeutics (NASDAQ: VBLT) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Ofra-Vec (VB-111) in combination with Paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

Benzinga

Expert Ratings for Nkarta

Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter:

Benzinga

Looking Into AMAZON.COM Inc's Recent Short Interest

AMAZON.COM Inc's (NASDAQ:AMZN) short percent of float has fallen 13.54% since its last report. The company recently reported that it has 3.65 million shares sold short, which is 0.83% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyst Ratings for Zillow Gr

Zillow Gr (NASDAQ:ZG) has observed the following analyst ratings within the last quarter:

Benzinga

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Old National Bancorp: Q1 Earnings Insights

Old National Bancorp (NASDAQ:ONB) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

United Bankshares: Q1 Earnings Insights

United Bankshares (NASDAQ:UBSI) reported its Q1 earnings results on Tuesday, April 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings United Bankshares reported in-line EPS of $0.6 versus an estimate of $0.6.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Arrow Financial: Q1 Earnings Insights

Arrow Financial (NASDAQ:AROW) reported its Q1 earnings results on Tuesday, April 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

LCNB: Q1 Earnings Insights

LCNB (NASDAQ:LCNB) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Carter Bankshares: Q1 Earnings Insights

Carter Bankshares (NASDAQ:CARE) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

What 5 Analyst Ratings Have To Say About Werner Enterprises

Over the past 3 months, 5 analysts have published their opinion on Werner Enterprises (NASDAQ:WERN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Where Hub Group Stands With Analysts

Within the last quarter, Hub Group (NASDAQ:HUBG) has observed the following analyst ratings:

Benzinga

Camden National: Q1 Earnings Insights

Camden National (NASDAQ:CAC) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Home Bancorp Q1 Earnings

Home Bancorp (NASDAQ:HBCP) reported its Q1 earnings results on Tuesday, April 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Evoke Shares Skyrocket On New FDA Market Exclusivity For Gimoti Nasal Spray

The FDA has granted new drug product exclusivity to Evoke Pharma Inc's (NASDAQ:EVOK) Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults. Evoke now has exclusive marketing rights over three (3) years from the original date of approval under the Hatch-Waxman Act to protect the product from…

Benzinga

Recap: First Merchants Q1 Earnings

First Merchants (NASDAQ:FRME) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Franklin Electric Q1 Earnings

Franklin Electric (NASDAQ:FELE) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Upcoming Docuseries On FX, Hulu Takes A Critical Look At Elon Musk, Tesla's Self-driving Ambition

Walt Disney Co (NYSE: DIS) owned cable television channel FX will premiere a documentary series on Tesla Inc (NASDAQ: TSLA) CEO Elon Musk in collaboration with The

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Airbnb And 3 Other Stocks Insiders Are Selling

Although gold futures traded higher this morning on Tuesday, there were a few notable insider trades.

Benzinga

Recap: Northern Trust Q1 Earnings

Northern Trust (NASDAQ:NTRS) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Peoples Bancorp Q1 Earnings

Peoples Bancorp (NASDAQ:PEBO) reported its Q1 earnings results on Tuesday, April 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Benzinga

10 Financials Stocks Moving In Tuesday's Pre-Market Session

1 … 690 691 692 693

People

Elon Musk

28,550 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Progress Software Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.